Skip to content

Dexmedetomidine reduces agitation and urinary tract irritation in anesthesia recovery patients: a single center, prospective, double-blind randomized controlled study

Dexmedetomidine reduces agitation and urinary tract irritation in anesthesia recovery patients: a single center, prospective, double-blind randomized controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500107721
Enrollment
Unknown
Registered
2025-08-18
Start date
2025-09-01
Completion date
Unknown
Last updated
2025-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Restlessness during anesthesia recovery period (EA) and urinary tract irritation sign (CRBD)

Interventions

study group:Dexmedetomidine
control group:Conventional anesthesia recovery

Sponsors

WeiHai Municipal Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age >= 18 years old, no gender restrictions; 2.Planned abdominal surgery (open or laparoscopic) under general anesthesia with endotracheal intubation, with a duration of >= 2 hours; 3.Intraoperative catheterization is required, and postoperative catheterization is carried into the anesthesia recovery room; 4.Can cooperate with communication and complete follow-up indicators; 5.Sign the informed consent form;

Exclusion criteria

Exclusion criteria: 1.Previous history of major surgeries, such as open abdominal surgery, craniotomy, thoracotomy, etc; 2.Emergency surgery; 3.Allergies to research drugs; 4.Patients with mental illness cannot cooperate with follow-up visits; 5.There are other contraindications for general anesthesia or catheterization;

Design outcomes

Primary

MeasureTime frame
restless;Urinary tract irritation;

Secondary

MeasureTime frame
pain;vital signs;nausea and vomiting;Wake-up time;

Countries

China

Contacts

Public ContactSun Weili

WeiHai Municipal Hospital

215228209@qq.com+86 631 5287617

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026